Maternal-Fetal Medicine Units (MFMU) studies of inhaled corticosteroids during pregnancy

Citation
M. Dombrowski et al., Maternal-Fetal Medicine Units (MFMU) studies of inhaled corticosteroids during pregnancy, J ALLERG CL, 103(2), 1999, pp. S356-S359
Citations number
2
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
ISSN journal
00916749 → ACNP
Volume
103
Issue
2
Year of publication
1999
Part
2
Supplement
S
Pages
S356 - S359
Database
ISI
SICI code
0091-6749(199902)103:2<S356:MMU(SO>2.0.ZU;2-#
Abstract
Few prospective clinical trials exist to address the use of asthma medicati ons during pregnancy in relation to neonatal outcomes. There is a need to i dentify favorable pregnancy outcomes in relation to the successful treatmen t of pregnant women with asthma. To this end, 3 studies have been initiated : (1) a retrospective analysis of inhaled steroid use in a maternal-fetal m edicine research center, (2) a large observational cohort study assessing t he effects of different types of asthma treatments on perinatal outcomes, a nd (3) a randomized clinical trial comparing theophylline and inhaled beclo methasone in the treatment of pregnant women with moderately severe asthma. Preliminary information on all 3 studies is described.